![]() |
市場調查報告書
商品編碼
2085733
醫用體溫監測設備市場:2026-2032年全球市場預測(依設備類型、監測模式、連接方式、電源、病患年齡層及應用領域分類)Healthcare Temperature Monitoring Devices Market by Device Type, Monitoring Mode, Connectivity Type, Power Source, Patient Age Group, Application - Global Forecast 2026-2032 |
||||||
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計到 2032 年,醫用體溫計市場規模將達到 45.5 億美元,複合年成長率為 6.11%。
| 主要市場統計數據 | |
|---|---|
| 基準年 2025 | 30億美元 |
| 預計年份:2026年 | 31.8億美元 |
| 預測年份 2032 | 45.5億美元 |
| 複合年成長率 (%) | 6.11% |
醫用體溫計已從最初僅能即時測量體溫的基本體溫計發展成為支持診斷、感染預防、手術全期護理、新生兒護理、遠端患者監護以及最佳化醫院工作流程的聯網臨床工具。此類產品包括數位體溫計、鼓膜和顳動脈體溫計、紅外線非接觸式體溫計、連續深部體溫探頭、穿戴式貼片以及整合式病患監測模組。
醫療體溫監測設備市場正經歷一場變革,從間歇性的人工測量轉向連續、連網且與工作流程整合的體溫監測。醫院和診所對能夠降低交叉感染風險、在所有年齡層和臨床情況下提供可靠讀數,並能與電子健康記錄、床邊監視器和遠端患者監護平台整合的設備的需求日益成長。
人工智慧 (AI) 透過提高訊號品質、識別異常體溫趨勢以及結合體溫數據與心率、呼吸頻率、血氧飽和度、血壓和臨床狀態,支持早期發現患者病情惡化,從而為醫療領域的體溫監測增添價值。在持續監測、虛擬病房、重症監護、術後復健和後期護理計畫中,人工智慧驅動的分析尤其重要,因為在這些應用中,解讀趨勢比解讀單次測量值更有價值。
亞太地區的需求成長主要受以下因素驅動:醫院基礎設施的不斷擴張、龐大的病患群體、多個經濟體醫療保健支出的成長,以及中國、印度、日本、韓國、澳洲和東協市場對數位醫療的快速普及。在感染疾病控制、婦幼保健計畫以及都市區醫院和分散式醫療機構中,對耐用、經濟且易於使用的體溫監測設備的需求推動了市場發展。在北美,人們對互聯監測、感染控制、FDA批准的技術、醫院間互通性以及電子健康記錄(EHR)在急診、門診、長期護理和家庭醫療居家醫療項目中的整合仍然保持著濃厚的興趣。
東協地區的需求與醫療保健服務的普及、醫院現代化、醫療旅遊以及都市區醫療中心數位化工具的日益普及密切相關;而在農村和社區醫療機構,耐用、價格合理且易於操作的設備仍然是首選。海灣合作理事會(GCC)國家正在投資建立智慧醫院、互聯醫療模式、遠端醫療平台以及引進高品質的進口醫療技術,這為具備互通性、網路安全措施和強大服務支援的高階監測系統創造了機會。歐盟強調在整個採購和上市後監管過程中,以循證實踐為基礎進行部署,遵守醫療設備法規(MDR),注重隱私保護,永續性,並要求提供全生命週期文件。
美國在互聯病患監測、FDA批准的設備、醫院間互通性、遠距醫療項目和感染預防方案方面處於主導。而加拿大則優先考慮公共衛生系統的可靠性、採購品質、病人安全以及在地理位置分散的社區中實現公平的醫療服務取得。墨西哥和巴西的需求涵蓋私立醫院、公立診所、急救醫療服務和感染疾病監測等領域,基於價值的採購、分銷商的能力和服務可用性都會影響採購決策。
行業領導者應優先考慮經臨床檢驗的準確性、快速測量、衛生設計、患者舒適度以及與醫院資訊系統、床邊監護儀和遠端患者監護平台的無縫整合。產品系列應涵蓋適用於大批量常規護理的經濟型設備,以及適用於重症監護、手術全期護理、新生兒護理、急診醫學、長期護理和家庭患者管理的先進連續監測解決方案。
本研究採用綜合方法,結合了公共衛生機構、監管機構、標準化組織、臨床文獻、採購趨勢、醫療技術採納指標和醫療設備監管資料庫的二手研究資料。所檢視的證據包括世界衛生組織 (WHO)、美國疾病管制與出版刊物中心 (CDC)、美國食品藥物管理局 (FDA)、歐洲疾病預防控制中心 (ECDC)、國際標準化組織 (ISO)、國際電工委員會 (IEC) 以及(如適用)當地醫療設備監管機構的指南和出版物,重點關注與生命徵象監測、感染互通性和檢驗資訊相關的資訊。
醫用體溫計正成為現代互聯醫療的重要組成部分。最具戰略意義的機會在於那些能夠兼顧臨床準確性、感染控制優勢、互通性、易用性、病患舒適度和基於依從性的資料處理的設備。持續性和穿戴式式解決方案正在拓展體溫計的功能,使其不再局限於常規生命徵象測量,而是擴展到主動患者監測和基於趨勢的臨床洞察。
The Healthcare Temperature Monitoring Devices Market is projected to grow by USD 4.55 billion at a CAGR of 6.11% by 2032.
| KEY MARKET STATISTICS | |
|---|---|
| Base Year [2025] | USD 3.00 billion |
| Estimated Year [2026] | USD 3.18 billion |
| Forecast Year [2032] | USD 4.55 billion |
| CAGR (%) | 6.11% |
Healthcare temperature monitoring devices have evolved from basic point-in-time thermometers into connected clinical tools that support diagnosis, infection prevention, perioperative care, neonatal care, remote patient monitoring, and hospital workflow optimization. The category includes digital thermometers, tympanic and temporal artery thermometers, infrared non-contact systems, continuous core temperature probes, wearable patches, and integrated patient monitoring modules.
Demand is supported by the clinical importance of body temperature as a core vital sign and by public health guidance recognizing fever measurement as useful, but not sufficient, as a stand-alone diagnostic screen. Healthcare buyers are prioritizing measurement accuracy, speed, hygiene, interoperability, patient comfort, and regulatory compliance as hospitals, clinics, long-term care facilities, and home care programs shift toward safer, data-enabled care delivery.
The healthcare temperature monitoring devices landscape is being reshaped by the transition from episodic manual measurement to continuous, connected, and workflow-integrated temperature monitoring. Hospitals and clinics increasingly require devices that reduce cross-contamination risk, capture reliable readings across age groups and clinical conditions, and connect with electronic health records, bedside monitors, and remote patient monitoring platforms.
Regulatory expectations are also influencing product strategy. Manufacturers must align with medical device quality systems, electrical safety and electromagnetic compatibility requirements, usability engineering, cybersecurity expectations, and region-specific frameworks such as U.S. FDA requirements and the European Medical Device Regulation. Procurement teams are evaluating total cost of ownership, calibration support, data security, clinical evidence, and service reliability rather than device price alone.
Artificial intelligence is adding value to healthcare temperature monitoring by improving signal quality, identifying abnormal temperature trends, and supporting earlier recognition of patient deterioration when temperature data is combined with heart rate, respiratory rate, oxygen saturation, blood pressure, and clinical context. AI-enabled analytics are especially relevant in continuous monitoring, virtual wards, intensive care, post-operative recovery, and post-acute care programs where trend interpretation can be more useful than isolated readings.
The cumulative impact of AI depends on validation, governance, and transparent performance claims. Algorithms used for clinical decision support may fall under software as a medical device expectations, requiring documented risk management, bias assessment, cybersecurity controls, and real-world performance monitoring. AI should enhance clinical workflows, alarm prioritization, and care team awareness while preserving clinician judgment and standardized diagnostic protocols.
Asia-Pacific is supported by expanding hospital infrastructure, large patient populations, rising healthcare expenditure in several economies, and accelerated adoption of digital health in China, India, Japan, South Korea, Australia, and ASEAN markets. Demand is reinforced by infectious disease preparedness, maternal and child health programs, and the need for durable, affordable, and easy-to-use temperature monitoring devices across both urban hospitals and decentralized care settings. North America remains highly focused on connected monitoring, infection control, FDA-cleared technologies, hospital interoperability, and electronic health record integration across acute care, ambulatory care, long-term care, and home health programs.
Europe is shaped by Medical Device Regulation compliance, GDPR-driven data protection, public procurement scrutiny, and strong demand for clinically validated monitoring in acute, long-term, and elderly care environments. Latin America is advancing through public health modernization, private hospital investment, and growing attention to infectious disease surveillance, although service networks and affordability remain important purchasing factors. The Middle East is adopting smart hospital systems, telehealth, and remote monitoring in high-investment health systems, particularly where national health transformation plans prioritize digital care. Africa shows long-term opportunity where robust, low-maintenance, battery-efficient, and affordable devices can strengthen primary care, maternal health, emergency response, and outbreak readiness.
ASEAN demand is linked to healthcare access expansion, hospital modernization, medical tourism, and greater use of digital tools in urban medical centers, while rural and community care settings continue to favor durable, affordable, and simple-to-train devices. The GCC is investing in smart hospitals, connected care models, telehealth platforms, and high-quality imported medical technologies, creating opportunities for premium monitoring systems with interoperability, cybersecurity readiness, and strong service support. The European Union emphasizes evidence-based adoption, MDR conformity, privacy-by-design, sustainability, and lifecycle documentation across procurement and post-market surveillance.
BRICS countries represent scale-driven opportunity because of large populations, public hospital procurement, infectious disease surveillance needs, and domestic manufacturing ambitions. G7 markets generally set high benchmarks for clinical evidence, device quality, cybersecurity, interoperability, reimbursement alignment, and patient safety expectations. NATO member countries add demand for resilient medical supply chains, deployable healthcare systems, emergency preparedness, and reliable monitoring technologies for military, humanitarian, disaster response, and civilian healthcare settings.
The United States leads in connected patient monitoring, FDA-cleared devices, hospital interoperability, remote care programs, and infection prevention protocols, while Canada prioritizes public health system reliability, procurement quality, patient safety, and equitable access across geographically dispersed communities. Mexico and Brazil show demand across private hospitals, public clinics, emergency care, and infectious disease surveillance needs, with value-based procurement, distributor capability, and service availability influencing purchasing decisions.
In Europe, the United Kingdom emphasizes NHS workflow efficiency, remote monitoring, and standardized procurement; Germany prioritizes high-quality hospital technology, engineering reliability, and regulatory rigor; France focuses on public hospital modernization and connected care; Italy and Spain balance aging populations with cost-sensitive procurement and regional healthcare delivery models; and Russia maintains demand for domestic and imported technologies amid complex supply and regulatory conditions. Across these countries, clinical validation, MDR alignment where applicable, cybersecurity, and data protection remain central to adoption.
China is scaling domestic production, hospital digitization, and connected medical infrastructure, while India is driven by healthcare access expansion, affordability, public health needs, and a fast-growing network of private providers. Japan emphasizes precision, reliability, and aging-care use cases, Australia prioritizes standards-based procurement, remote healthcare delivery, and resilient supply chains, and South Korea combines advanced hospital digitization with strong medical technology capabilities. Each country rewards suppliers that can prove accuracy, usability, compliance, after-sales reliability, training support, and compatibility with established clinical workflows.
Industry leaders should prioritize clinically validated accuracy, fast measurement, hygienic design, patient comfort, and seamless integration with hospital information systems, bedside monitors, and remote patient monitoring platforms. Product portfolios should include both cost-effective devices for high-volume routine care and advanced continuous monitoring solutions for intensive care, perioperative care, neonatal care, emergency care, long-term care, and home-based patient management.
Manufacturers should strengthen regulatory documentation, cybersecurity architecture, calibration programs, usability testing, multilingual training, and post-market surveillance. Commercial teams can improve competitiveness by offering service contracts, localization, distributor training, clinical education, and evidence packages that demonstrate workflow impact, reduced manual documentation burden, infection-control benefits, and compatibility with established clinical protocols.
The research approach combines secondary research from public health agencies, regulatory bodies, standards organizations, clinical literature, procurement trends, healthcare technology adoption indicators, and medical device regulatory databases. Evidence considered includes guidance and publications from organizations such as WHO, CDC, FDA, ECDC, ISO, IEC, and regional medical device authorities where applicable, with emphasis on verified information related to vital sign monitoring, infection prevention, device safety, interoperability, and data protection.
Primary validation should include interviews with clinicians, biomedical engineers, procurement leaders, distributors, regulatory specialists, and device manufacturers. Findings are strengthened through triangulation across regulatory evidence, clinical use cases, product benchmarking, regional healthcare investment patterns, standards alignment, and technology adoption signals to ensure conclusions are practical, current, and decision-ready without relying on unverified estimates or speculative projections.
Healthcare temperature monitoring devices are becoming essential components of modern connected care. Strategic opportunity is strongest where devices combine clinical accuracy, infection-control advantages, interoperability, usability, patient comfort, and compliant data handling. Continuous and wearable solutions are expanding the role of temperature measurement from routine vital sign capture to proactive patient surveillance and trend-based clinical awareness.
The next phase of competition will be defined by evidence, integration, and trust. Organizations that align with regulatory expectations, validate performance across diverse clinical environments, and support healthcare providers with reliable service models will be well positioned to meet demand across hospitals, clinics, long-term care, home care, emergency response, and public health programs.